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Introduction {#sec1}
============

T cells are involved in most adaptive immune responses. The hallmark of T cell responses is the variability of T cell receptors (TCRs) among individual T cell clones. The interaction between the TCR and its cognate antigen (i.e., a peptide bound to major histocompatibility complex class I \[MHCI\] or MHCII molecules) on the surface of an antigen-presenting cell (APC) leads to the activation of the T cell and the initiation of the immune response.

There are two basic types of T cells, MHCI-restricted CD8^+^ T cells and MHCII-restricted CD4^+^ T cells. CD8^+^ T cells are involved in direct killing of infected cells, whereas CD4^+^ T cells orchestrate immune responses by acting on other immune cells. Invariant coreceptors CD4 and CD8 bind to MHCI and MHCII, respectively, to promote the TCR signaling. One of the major roles of the coreceptors is to recruit a kinase LCK to the TCR signaling complex, which, in turn, leads to the phosphorylation of the TCR-associated chains and the initiation of the downstream signaling ([@bib1], [@bib51], [@bib39], [@bib52], [@bib2]). The interaction between the coreceptor and LCK regulates the sensitivity of T cells to the antigen ([@bib10], [@bib48], [@bib7]).

Besides their key role in protective immunity, T cells can induce harmful autoimmunity, depending on whether they respond to foreign or self-antigens. A central mechanism establishing self-tolerance is the negative selection of highly self-reactive T cells during their maturation in the thymus. However, a certain level of self-reactivity of mature T cells is required because only the self-pMHC-restricted pool of T cells can efficiently recognize foreign antigens. This is achieved by positive selection of developing T cells with moderate reactivity to self-antigens in the thymus. The stoichiometry of the coreceptor-LCK interaction sets up the "selection window" by establishing the thresholds for positive and negative selection of developing T cells ([@bib10], [@bib48]).

There is an increasing amount of evidence showing that the actual level of self-reactivity largely determines T cell responses to foreign cognate antigens. It has been shown that the level of self-reactivity correlates with the ability of T cells to recognize foreign antigens with high affinity ([@bib31]). A comparison of two CD4^+^ T cell clones with identical affinity for the cognate antigen revealed that the less self-reactive clone expanded more in the primary response, whereas the more self-reactive clone dominated the recall response ([@bib54], [@bib38]). Other studies showed that priming of T cells by self-antigens enhances their subsequent responses to foreign antigens and that highly self-reactive T cells have an advantage over weekly self-reactive T cells in this respect ([@bib13], [@bib49], [@bib46]). Overall, the self-reactivity of T cells is beneficial for immune protection, but at the same time, it represents the risk for the onset of autoimmunity. Apparently, there is an optimal level of self-reactivity that balances these two counteracting phenomena. This optimal level of self-reactivity can be established by correct setting of the thresholds for positive and negative selection in the thymus and/or by eventual changes in the sensitivity of the TCR signaling machinery during T cell maturation. Considering fundamental differences in the roles of CD8^+^ and CD4^+^ T cells, it is very plausible that the optimal levels of self-reactivity might substantially differ between these two populations.

We and others showed that CD4-LCK and CD8-LCK binding stoichiometry is a limiting factor for signaling induced by suboptimal self-antigens in immature thymocytes ([@bib10], [@bib48]). Moreover, we have recently revealed that the CD8-LCK binding frequency regulates tonic TCR signaling in peripheral T cells and the generation of virtual memory T cells from relatively highly self-reactive CD8^+^ T cells ([@bib7]). However, the stoichiometry of CD4-LCK and CD8-LCK interactions in mature T cells has not been addressed in detail.

In this study, we observed that the stoichiometry of the CD8-LCK, but not CD4-LCK, interaction is dynamically regulated during development. The percentage of CD8 molecules carrying LCK is substantially higher in mature T cells than in thymocytes at the double positive (DP) stage, where the positive selection and most of the negative selection takes place. Consequently, CD8^+^ T cells increase their responsiveness to antigens with suboptimal affinity upon maturation. Moreover, CD8^+^ T cells are, on average, more self-reactive than CD4^+^ T cells. Our observation seems to be a result of an evolutionary adaptation that took advantage of the different use of coreceptors by MHCI- and MHCII-restricted T cells to tune the optimal level of self-reactivity for these two subsets independently.

Results {#sec2}
=======

CD8-LCK Coupling Frequency Is Dynamically Regulated during T Cell Maturation {#sec2.1}
----------------------------------------------------------------------------

The stoichiometry of the CD4-LCK and CD8-LCK interactions has been previously analyzed using a semiquantitative method of immunoprecipitation followed by flow cytometry (FC-IP) in preselection DP thymocytes ([@bib48]). In this study, we applied this method to mature peripheral T cells. This method is based on of the immunoprecipitation of CD4 or CD8 by using antibody-coated beads, followed by the detection of coreceptor and LCK molecules by flow cytometry. We used NP-40S detergent for cell lysis that extracted the vast majority of CD4, CD8, and LCK molecules from thymocytes and lymph node (LN) cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A), excluding the possibility that our results are influenced by a potential insolubility of these proteins. We used an anti-CD8β antibody for pull down and anti-CD8α for detection to exclude eventual CD8αα homodimers that do not promote TCR signaling ([@bib55]). For the pull down and detection of CD4, two non-competing antibody clones were used ([Figures S1](#mmc1){ref-type="supplementary-material"}B--S1D). The concentration of the detection antibodies was titrated to use saturating concentrations ([Figure S1](#mmc1){ref-type="supplementary-material"}E).

In agreement with the previous study ([@bib48]), we observed a substantially higher frequency of LCK-coupled CD4 coreceptors than CD8 coreceptors in DP thymocytes ([Figure 1](#fig1){ref-type="fig"}A). Interestingly, the difference between CD4-LCK and CD8-LCK interactions was much less pronounced in mature peripheral T cells than in DP thymocytes ([Figure 1](#fig1){ref-type="fig"}A). Upon T cell maturation, the CD8-LCK binding stoichiometry increased ∼13-fold, whereas the percentage of CD4 molecules coupled to LCK increased only ∼2-fold ([Figure 1](#fig1){ref-type="fig"}A).Figure 1The Dynamics of the Coreceptor-LCK Coupling Predicts Self-Reactivity(A) Mature T cells or DP thymocytes were lysed and incubated with beads coated with antibodies to CD4 (RM4-4) or CD8β (53-5.8). Beads were probed with PE-conjugated antibodies to LCK (3a5), CD8α (53-5.7), or CD4 (H129.19) and analyzed by flow cytometry. Calculated CD4-LCK or CD8-LCK stoichiometry for thymocytes and mature T cells is shown. Mean + SEM; n = 3--5 mice in 3--4 independent experiments.(B and C) CD4 (H129.19) or CD8β (53-5.8) were immunoprecipitated from lysates of thymocytes or enriched peripheral CD8^+^ and CD4^+^ T cells from WT mice, followed by immunoblotting using anti-CD4 (D7D2Z), anti-CD8α (D4W2Z). and anti-LCK (3a5) antibodies. (B) Representative experiments for CD8β and CD4 immunoprecipitation. CD8α\' truncated isoform is marked with an asterisk. (C) Ratio of LCK-coupled coreceptors (periphery/thymus). Mean + SEM; n = 3--5 samples (pooled 2--3 mice) in 3--4 independent experiments.(D) TCR signal intensity predicted by the "LCK come&stay/signal duration model" ([@bib48]) induced by strong cognate or suboptimal antigens (at the threshold for negative selection) in MHCI- or MHCII-restricted DP or mature T cells. The TCR signal intensity corresponds to the number of signaling TCRs and is shown as a function of antigen density. The input data correspond to the parameters obtained from monoclonal OT-I and B3K508 T cells ([@bib48]).(E) Schematic illustration of the prediction of the mathematical model applied to the process of T cell selection. The coreceptor-LCK coupling in the thymocytes sets the self-antigen affinity window of the positively selected T cell, resulting in higher affinity to self-antigens in the MHCI-restricted than in the MHCII-restricted T cells. Increased CD8-LCK, but not CD4-LCK, coupling frequency in mature T cells leads to the increased sensitivity of peripheral CD8 T cells to suboptimal antigens. Altogether, mature CD8^+^ T cells have, on average, higher level of self-reactivity than CD4^+^ T cells.See also [Figure S1](#mmc1){ref-type="supplementary-material"}, [Table S1](#mmc1){ref-type="supplementary-material"}, and [Data S1](#mmc1){ref-type="supplementary-material"}.

We addressed the relative changes of coreceptor-LCK binding stoichiometries between thymocytes and mature T cells by using an independent technique. We performed conventional immunoprecipitation from cell lauryl-maltoside lysates followed by immunoblotting ([Figures 1](#fig1){ref-type="fig"}B and 1C). We observed differences in the apparent molecular weight of CD8α between thymocytes and peripheral T cells ([Figure 1](#fig1){ref-type="fig"}B). First, the apparent molecular weight of CD8α was lower in thymocytes than in peripheral T cells. This shift is caused by more intensive sialylation of CD8 in peripheral cells than in thymocytes ([@bib4], [@bib33], [@bib35]). Accordingly, the removal of the sialic acid chains by neuraminidase normalized the apparent molecular weight of CD8α but did not substantially affect the relative intensities of the detecting antibodies in immunoblotting or flow cytometry ([Figures S1](#mmc1){ref-type="supplementary-material"}F and S1G). Second, there was an additional lower band detected exclusively in the thymocytes ([Figure 1](#fig1){ref-type="fig"}B). This band corresponds to the truncated isoform CD8α' ([@bib58], [@bib57]). The analysis of the LCK to coreceptor ratio in this experiment showed that upon T cell maturation, the CD8-LCK binding stoichiometry increased ∼9-fold, whereas the percentage of CD4 molecules coupled to LCK increased only ∼2-fold. Thus, these results were in a good agreement with the FC-IP data.

The dramatic changes in CD8-LCK coupling frequency upon maturation is most likely caused by two factors. First, we and others observed that the truncated isoform CD8α' devoid of the LCK-binding site is present in thymocytes but not in peripheral T cells ([Figure 1](#fig1){ref-type="fig"}B). Interestingly, the expression of CD8α' is regulated post-transcriptionally, as there is almost no difference in the CD8α'-encoding RNA levels between the two T cell stages ([Figure S1](#mmc1){ref-type="supplementary-material"}H) ([@bib57]). However, CD8α' constitutes only ∼30% of the total CD8α in thymocytes ([Figure S1](#mmc1){ref-type="supplementary-material"}I), suggesting that there must be an additional mechanism for the dynamic regulation of CD8-LCK coupling. Because the vast majority of LCK molecules are coupled to CD4 or CD8 in DP thymocytes ([@bib50]) and because CD4 has been shown to have higher affinity to LCK than CD8 has *in vitro* ([@bib22]), CD4 sequesters LCK from CD8 at the DP stage, which does not occur in mature CD8^+^ T cells.

We previously developed the "LCK come&stay/signal duration model" to predict TCR signaling output by using a set of parameters including TCR density, antigen affinity, and coreceptor-LCK stoichiometry ([@bib48]). The model is based on the kinetic proof-reading principle ([@bib32]). It assumes that LCK recruitment and phosphorylation of the TCR/ZAP70 complex must be accomplished during the interaction of the TCR with the pMHC to trigger the TCR. The model assumes that the triggered TCR continuously transduces the signal downstream as long as it is occupied by the antigen. This model was the only one among a couple of constructed models that could explain the importance of the coreceptor-LCK binding in the antigen affinity discrimination in DP thymocytes, which was observed experimentally ([@bib48]). We use this relatively simplistic model here to obtain testable predictions of how the dynamics of CD4-LCK and CD8-LCK coupling regulates the T cell responses to antigens. To assess how the differences in the dynamics of CD4-LCK and CD8-LCK coupling influences the TCR signaling, we used our experimental CD4- and CD8-LCK stoichiometry data as well as the quantification of the percentage of phosphorylated LCK molecules, and the TCR levels on mature CD4^+^ and CD8^+^ T cells ([Figures S1](#mmc1){ref-type="supplementary-material"}J--S1M, [Table S1](#mmc1){ref-type="supplementary-material"}) as inputs for the LCK come&stay/signal duration model.

The model predicts that MHCI- and MHCII-restricted T cells and DP thymocytes exhibit comparable responses to their high-affinity cognate antigens ([Figure 1](#fig1){ref-type="fig"}D). However, the stoichiometry of the coreceptor-LCK interaction was shown to be limiting, specifically for signaling induced by suboptimal antigens ([@bib10], [@bib48], [@bib7]). We took advantage of the fact that the affinities to self-antigens at the threshold for negative selection are known for both MHCI-restricted and MHCII-restricted thymocytes ([@bib5], [@bib37], [@bib48]), and we used these parameters in the mathematical model. The model predicts that partial-negative-selecting antigens induce stronger TCR signaling in CD8^+^ mature peripheral T cells than in peripheral CD4^+^ T cells or in MHCI- and MHCII-restricted DP thymocytes ([Figure 1](#fig1){ref-type="fig"}D). These results suggest that peripheral MHCI-restricted CD8^+^ T cells, but not MHCII-restricted CD4^+^ T cells, could be activated by positive selecting or only partial negative selecting self-antigens.

CD8^+^ T Cells Are More Reactive to Suboptimal Antigens Than CD4^+^ T Cells *Ex Vivo* {#sec2.2}
-------------------------------------------------------------------------------------

Based on the dynamics of the CD4- and CD8-LCK binding stoichiometry and the predictions of the mathematical model, we hypothesize that MHCI-restricted T cells, but not MHCII-restricted T cells, increase their sensitivity to suboptimal antigens upon maturation. We reasoned that CD8^+^ T cells are, therefore, on average more self-reactive than CD4^+^ T cells ([Figure 1](#fig1){ref-type="fig"}E). In the next steps, we addressed our hypothesis experimentally.

We used monoclonal mature T cells and thymocytes from *Rag2*-deficient mice bearing either MHCI-restricted OT-I-transgenic TCR (specific to H-2K^b^-SIINFEKL; OVA) or MHCII-restricted B3K508-transgenic TCR (specific to H-2A^b^-FEAQKAKANKAKAVD; 3K) as our experimental model. The advantage of these monoclonal models is that there is a wide range of well-characterized cognate-altered peptide ligands covering negative selectors, partial negative selectors, and positive selectors ([@bib5], [@bib18], [@bib21], [@bib48]; [Figure S2](#mmc1){ref-type="supplementary-material"}A). TCR expression is higher in B3K508 T cells than in OT-I T cells, mimicking the situation in polyclonal T cells ([Figures S1](#mmc1){ref-type="supplementary-material"}M and [S2](#mmc1){ref-type="supplementary-material"}B).

Upon overnight stimulation with bone-marrow-derived dendritic cells (BMDCs) pulsed with the cognate peptides or their lower affinity variants, we measured the expression of an activation marker, CD69, in the monoclonal T cells and thymocytes ([Figures 2](#fig2){ref-type="fig"}A, 2B, [S2](#mmc1){ref-type="supplementary-material"}C, and [S2](#mmc1){ref-type="supplementary-material"}D). We compared CD69 upregulation in mature T cells and DP thymocytes by calculating the ratio of the corresponding areas under curve for each antigen ([Figure 2](#fig2){ref-type="fig"}B) or the ratio of the maximal response ([Figure S2](#mmc1){ref-type="supplementary-material"}D). The responses of OT-I and B3K508 mature T cells and DP thymocytes to the high-affinity antigens (OVA and 3K, respectively) were comparable. However, the mature OT-I T cells exhibited stronger responses than DP thymocytes when stimulated with suboptimal antigens T4 and Q4H7, a partial negative selector and a positive selector, respectively ([Figures 2](#fig2){ref-type="fig"}A, 2B, [S2](#mmc1){ref-type="supplementary-material"}C, and S2D). In the case of B3K508 mice, the mature T cells and DP thymocytes showed comparable responses to suboptimal antigens P2A and P-1A, a relatively weak negative selector and a partial negative selector, respectively ([Figures 2](#fig2){ref-type="fig"}A, 2B, [S2](#mmc1){ref-type="supplementary-material"}C, and S2D).Figure 2CD8^+^ T Cells Are More Sensitive to Suboptimal Antigens Than CD4^+^ T Cells *In Vitro*LN T cells or thymocytes from OT-I mice (blue) or B3K508 mice (red) were stimulated by BMDCs loaded with indicated concentrations of indicated peptides overnight.(A and B) CD69 levels on T cells were analyzed by flow cytometry. EC~50~ concentrations of peptides are indicated (A). The ratio of the area under curve of the % CD69^+^ T cells in the periphery versus thymus (B). Mean + SEM; n = 4 mice in 4 independent experiments.(C and D) The cells were stimulated by BMDCs loaded with a 10^−5^-M concentration of indicated peptides, fixed at indicated time points, and analyzed for phosphorylation of ERK1/2 by flow cytometry. Mean + SEM; n = 6--10 independent experiments (C). The ratio of area under curve of % pERK1/2^+^ T cells in the periphery versus thymus. Mean + SEM, n = 6--10 mice in 6--10 independent experiments (D). Statistical analysis was performed using 2-tailed Mann-Whitney test.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

In a next step, we studied a proximal TCR signaling event, a phosphorylation of kinases ERK1 and ERK2 ([Figures 2](#fig2){ref-type="fig"}C, 2D and [S2](#mmc1){ref-type="supplementary-material"}E--S2G). As the mature T cells and DP thymocytes had distinct kinetics of ERK1/2 phosphorylation, we used the overall response calculated as the area under curve ([Figure 2](#fig2){ref-type="fig"}D) or maximal response ([Figure S2](#mmc1){ref-type="supplementary-material"}G) for quantification. We calculated the mature T cell/DP thymocytes ratio for each antigen. In the case of OT-I T cells, mature T cells showed an ∼4.5-fold stronger overall response than DP thymocytes to both the high-affinity antigen OVA and the suboptimal antigen T4 ([Figures 2](#fig2){ref-type="fig"}C and 2D). However, B3K508 mature T cells showed a substantially stronger response to the high-affinity antigen than DP thymocytes (∼6.5-fold), but the responses of B3K508 mature T cells and DP thymocytes to suboptimal antigens P2A and P-1A were comparable ([Figures 2](#fig2){ref-type="fig"}C and 2D).

Overall, CD69 upregulation and pERK1/2-phosphorylation were in line with the mathematical model predicting that the responses to suboptimal antigens are augmented upon maturation of MHCI-restricted, but not MHCII-restricted, T cells. However, it should be noted here that the responses of B3K508 T cells to P2A (pERK1/2) and P-1A (both pERK1/2 and CD69) were weak, which limits our conclusions.

CD8^+^ T Cells Are More Reactive to Suboptimal Antigens Than CD4^+^ T Cells *In Vivo* {#sec2.3}
-------------------------------------------------------------------------------------

We next examined the activation of T cells *in vivo*. In this assay, we took advantage of the fact that the ability of particular antigens to induce negative selection in OT-I and B3K508 thymocytes has been established previously ([@bib5], [@bib18], [@bib21], [@bib48], [@bib56]). Thus, we could monitor T cell responses to high-affinity cognate antigens and partial-negative-selecting antigens in the periphery. We transferred CFSE-labeled OT-I and B3K508 peripheral T cells into congenic Ly5.1 mice. Subsequently, we infected the mice with *Listeria monocytogenes* (*Lm*) expressing the cognate antigens for the transferred T cells. We analyzed the expansion, proliferation, and CD25 upregulation in the donor T cells 4 days later. Both OT-I and B3K508 T cells exhibited strong proliferation, expansion, and CD25 upregulation upon infection, with *Lm* carrying the respective high-affinity cognate antigens (OVA and 3K) ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Figures S3](#mmc1){ref-type="supplementary-material"}A--S3D). In the case of OT-I T cells, *Lm* carrying the partial-negative-selecting antigen T4 or even a positive-selecting antigen Q4H7 induced substantial expansion, proliferation, and CD25 upregulation, whereas non-cognate empty *Lm* did not induce a detectable response ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). In striking contrast to OT-I T cells, B3K508 T cells did not respond to *Lm* expressing the partial-negative-selecting antigen P-1A ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Collectively, these data reveal that peripheral CD8^+^ T cells show a robust *in vivo* response to antigens with low affinity as partial negative selectors or even positive selectors, whereas peripheral CD4^+^ T cells are not able to respond to partial-negative-selecting antigens at all.Figure 3CD8^+^ T Cells Are More Sensitive to Suboptimal Antigens Than CD4^+^ T Cells *In Vivo*CFSE-loaded LN cells from OT-I mice and B3K508 mice were injected into congenic Ly5.1 WT mice. The mice were infected with transgenic *Lm* expressing indicated peptides. Four days after the infection, viable splenic donor T cells (gated as CD3^+^ CD4^+^ Va2^+^ Ly5.2^+^ for B3K508 T cells and CD3^+^ CD8^+^ Va2^+^ Ly5.2^+^ for OT-I T cells) were analyzed for proliferation (CFSE) and CD25 expression by flow cytometry.(A) Representative animals out of 6--8 per group.(B) The percentage of donor cells among all splenic CD4^+^ or CD8^+^ T cells is shown. n = 6--8 mice in 4 independent experiments. Statistical analysis was performed using 2-tailed Mann-Whitney test.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

CD8^+^ T Cells Experience Stronger Homeostatic TCR Signals Than CD4^+^ T Cells {#sec2.4}
------------------------------------------------------------------------------

The results of *in vitro* and *in vivo* assays using monoclonal MHCI- and MHCII-restricted T cells corresponded well to the predictions of the mathematical model. If we translate these findings to the polyclonal repertoire, we can hypothesize that the CD8^+^ T cell population is, on average, more self-reactive than the CD4^+^ population because only the CD8^+^ subset contains T cells that are able to respond to the positive- and partial-negative-selecting self-antigens at the periphery.

The self-reactivity of peripheral T cells determines the intensity of homeostatic signaling at the basal state. We generated and analyzed LCK-deficient mice to (1) validate our tools for the detection of proximal signaling intermediates of tonic signaling by using phospho-specific antibodies by flow cytometry and (2) to address the role of LCK in the homeostatic TCR signaling. The *Lck*^−/−^ thymocytes showed partial blocks in the β selection and positive selection ([Figure S4](#mmc1){ref-type="supplementary-material"}A), as previously reported ([@bib34]). Reduced LCK levels in heterozygous *Lck*^+/−^ and in *Lck*^−/−^ mice lead to a gradual decrease in TCRζ and ZAP70 phosphorylation and overall tyrosine phosphorylation in both CD4 and CD8 peripheral T cells ([Figure 4](#fig4){ref-type="fig"}A). These results show that LCK is a major factor regulating the strength of the homeostatic TCR signaling in resting peripheral T cells, which is in line with our model.Figure 4Polyclonal CD8^+^ T Cells Show Stronger Homeostatic TCR Signaling Than CD4^+^ T Cells(A--C) Fixed and permeabilized LN T cells from WT mice were stained with antibodies to TCRβ, CD4, CD8, pTCRζ chain, pZAP70, and overall tyrosine phosphorylation and analyzed by flow cytometry. Comparison of basal signaling in CD8^+^ CD44^−^ and CD4^+^ CD44^−^ T cells from *Lck*^+/+^, *Lck*^+/−^, and *Lck*^−/−^ mice. Phosphorylation level (geometric mean fluorescence intensity \[gMFI\]) relative to *Lck*^+/+^ mice is shown. Mean + SEM; n = 7 mice in 7 independent experiments. Statistical analysis was performed by one sample t test (hypothetical mean value = 1) (A). Comparison of basal signaling in CD4^+^ and CD8^+^ T cells. A representative experiment out of 5 independent experiments in total (B). Ratio of phosphorylation levels (gMFI) of CD8^+^ versus CD4^+^ peripheral T cells in pTCRζ, pZAP70, and overall tyrosine phosphorylation for each mouse. Mean; n = 5 mice in 4 independent experiments. Statistical analysis was performed by one sample t test (hypothetical mean value = 1) (C).(D) The LN, mLN, and splenic T cells of *Foxp3*-deficient mice and their WT littermates were analyzed by flow cytometry. The ratio of CD8^+^ to CD4^+^ T cells is shown. Mean; n = 4--5 mice from 2 experiments. Statistical analysis was performed by 2-tailed Mann-Whitney test.(E) The peripheral LN T cells from *Foxp3*-DTR mice after the administration of diptheria toxin, untreated *Foxp3*-DTR mice, and WT mice after the administration of diptheria toxin were analyzed. The ratio of CD8^+^ to CD4^+^ T cells is shown. n = 6 mice in 3 independent experiments; mean. Statistical analysis was performed by 2-tailed Mann-Whitney test.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

We examined the intensity of homeostatic TCR signaling to compare the level of self-reactivity of polyclonal peripheral CD4^+^ and CD8^+^ T cells. Higher levels of TCRζ and ZAP70 phosphorylation and overall tyrosine phosphorylation in CD8^+^ T cells than in CD4^+^ T cells suggested that CD8^+^ T cells receive stronger homeostatic signals from self-antigens than CD4^+^ T cells ([Figures 4](#fig4){ref-type="fig"}B and 4C). These observations were not substantially influenced by the inclusion of CD4^+^ regulatory T cells (Tregs), as the comparison of CD8^+^ T cells to conventional FOXP3^−^ CD4^+^ T cells showed similar results ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). Moreover, the higher intensity of basal TCR signaling in CD8^+^ T cells than in CD4^+^ T cells was not caused by higher surface TCR levels in CD8^+^ T cells. On the contrary, CD8^+^ T cells have a lower surface TCR expression than CD4^+^ T cells ([Figure S1](#mmc1){ref-type="supplementary-material"}M). Overall, these data supported the hypothesis that CD8^+^ T cells are more self-reactive than CD4^+^ T cells.

The higher level of self-reactivity of CD8^+^ T cells than of CD4^+^ T cells indicates that CD8^+^ T cells might be more susceptible to hyperproliferation than CD4^+^ T cells. To address this hypothesis, we used Treg deficiency as a model for a systemic breakdown of peripheral tolerance. We observed that the ratio of CD8^+^/CD4^+^ T cells is significantly higher in FOXP3-deficient 2- to 3-week-old mice devoid of Tregs than in the healthy littermates ([Figure 4](#fig4){ref-type="fig"}D). In a complementary assay, we observed the effect of acute depletion of Tregs by injecting diphtheria toxin (DT) into *Foxp3*-DTR mice, expressing the DT receptor in FOXP3^+^ T cells ([@bib23]). The CD8^+^/CD4^+^ T cell ratio significantly increased in adult Treg-depleted mice compared to untreated *Fox3*-DTR mice and to wild-type (WT) mice injected with the DT ([Figure 4](#fig4){ref-type="fig"}E). These results are consistent with the hypothesis that the polyclonal CD8^+^ T cell population receives stronger signals from self-antigens than the CD4^+^ T cell population and that CD8^+^ T cells are more prone to hyperproliferation than CD4^+^ T cells when the Treg-mediated tolerance fails. However, we cannot exclude that additional differences between CD8^+^ versus CD4^+^ (e.g., differential expression of cytokine receptors) play a role in this assay.

The Self-Reactivity of CD8^+^ T Cells Is Regulated by the Dynamics of the CD8-LCK Coupling {#sec2.5}
------------------------------------------------------------------------------------------

The previous experiments and the prediction of the mathematical model show substantial differences between CD8^+^ and CD4^+^ T cells in terms of their response to suboptimal antigens and the basal signaling. In a next step, we addressed the link between the coreceptor-LCK coupling and the self-reactivity of mature T cells directly. We took advantage of a previously developed CD8.4 knockin mouse model ([@bib7], [@bib10], [@bib48]). In this mouse, MHCI-restricted T cells express a chimeric CD8.4 coreceptor that has the intracellular domain of CD8α replaced by the intracellular domain of the CD4 coreceptor. The coupling of CD8.4 coreceptor to LCK is comparable to CD4 both in the thymus and at the periphery ([@bib48]) ([Figure 5](#fig5){ref-type="fig"}A). The basal phosphorylation of TCRζ in CD8.4 T cells was significantly lower than in CD8^+^ T cells, and the difference in the ZAP70 phosphorylation was close to significant ([Figure 5](#fig5){ref-type="fig"}B), indicating that peripheral CD8^+^ T cells are, on average, more self-reactive than CD8.4^+^ T cells. We obtained similar results when we repeated this key experiment in a different animal facility ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Because the phosphorylation of ZAP70 and TCRζ and overall tyrosine phosphorylation were only slightly increased in CD8.4^+^ compared with CD4^+^ T cells, we concluded that the changes in coreceptor-LCK stoichiometry during development are a major cause of the differences in basal TCR signaling between CD8^+^ and CD4^+^ T cells.Figure 5Role of Coreceptor-LCK Coupling in Self-Reactivity of T Cell Subpopulations(A) CD4-LCK, CD8-LCK, or CD8.4-LCK stoichiometry in LN T cells of WT and CD8.4 mice was analyzed. Mean + SEM; n = 4--9 mice from 4--8 independent experiments. Statistical analysis was performed by 2-tailed Mann-Whitney test. The CD4-LCK and CD8-LCK stoichiometries are the same as that shown in [Figure 1](#fig1){ref-type="fig"}A.(B) Ratio of MFI levels of pTCRζ, pZAP70, and overall tyrosine phosphorylation in CD8^+^ versus CD4^+^ peripheral T cells in WT and CD8.4 chimeric mice is shown. Mean, n = 5 mice in 3 independent experiments. Statistical analysis was performed by 2-tailed Mann-Whitney test. See [Figure S5](#mmc1){ref-type="supplementary-material"}D for similar data.(C and D) LN T cells from *Nur77*-GFP reporter mice were analyzed by flow cytometry. The CD8^+^ CD44^−^ CD62L^+^ or CD8.4^+^ CD44^−^ CD62L^+^ T cells were analyzed for the expression of the *Nur77*-GFP. The percentage of *Nur77*-GFP^+^ and *Nur77*-GFP^HIGH^ cells is shown. Mean; n = 3--6 mice in 3--6 independent experiments. Statistical analysis was performed by 2-tailed Mann-Whitney test.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Expression of an orphan nuclear receptor, *Nur77*, is very sensitive even to weak TCR signaling. For this reason, the *Nur77*-GFP reporter mouse has been used to study TCR signals induced by self-antigens ([@bib36]). The *Nur77*-GFP signal is stronger in CD4^+^ than in CD8^+^ T cells ([@bib36]) ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B), suggesting that CD4^+^ T cells might have stronger TCR signaling than CD8^+^ T cells. Because these results are contradictory to our analysis of basal TCR signaling ([Figures 4](#fig4){ref-type="fig"}B and 4C), we addressed it in a greater detail. We compared GFP expression in CD8^+^ *Nur77*-GFP and CD8.4^+^ *Nur77*-GFP T cells. We observed a significantly higher frequency of GFP^+^ and GFP^HIGH^ cells among CD8^+^ than among CD8.4^+^ T cells ([Figures 5](#fig5){ref-type="fig"}C and 5D; [Figure S5](#mmc1){ref-type="supplementary-material"}C), supporting our previous data that the dynamics of the coreceptor-LCK stoichiometry sets the level of T cell self-reactivity. In the light of these data, we suggest that the previously reported higher expression of *Nur77* in CD4^+^ T cells than in CD8^+^ T cells reflects a differential regulation of this gene in these two very different T cell types rather than the differences in basal TCR signaling per se.

The sizes of CD4, CD8, and CD8.4 naive T cells are comparable in terms of cellular dry mass ([Figure S5](#mmc1){ref-type="supplementary-material"}E) and forward scatter signal ([Figure S5](#mmc1){ref-type="supplementary-material"}F). The TCR levels are the highest in CD4 T cells and comparable in CD8 and CD8.4 T cells ([Figures S1](#mmc1){ref-type="supplementary-material"}M and [S5](#mmc1){ref-type="supplementary-material"}G). The expression level of ZAP70 is comparable among these cell types ([Figure S5](#mmc1){ref-type="supplementary-material"}H). Thus, we could exclude the possibility that the cell size variation or TCR or ZAP70 expression is responsible for the observed differences in the homeostatic TCR signaling.

Altogether, our data indicate that the stoichiometry of the CD4- and CD8-LCK interactions and their changes during T cell development establish the level of self-reactivity of mature T cells. The dynamic regulation of the CD8-LCK stoichiometry causes CD8^+^ T cells to be, on average, more self-reactive than CD4^+^ T cells.

Discussion {#sec3}
==========

Our results show that the developmental dynamics of CD4-LCK and CD8-LCK stoichiometries differ substantially in mice. A relatively high number of CD4 molecules are coupled to LCK in developing DP thymocytes ([@bib48]), and this coupling is only mildly increased during the maturation of CD4^+^ T cells. In contrast, CD8-LCK stoichiometry is relatively low in DP thymocytes ([@bib48]) when positive selection and most of the negative selection occurs. The number of CD8 molecules carrying LCK dramatically increases upon maturation. This is partially caused by the expression of the truncated CD8α' variant ([@bib58]). CD8α' is expressed only on the surface of thymocytes but not of mature T cells ([@bib57]). However, the major mechanism causing the low CD8-LCK coupling in DP thymocytes is the preferential sequestering of LCK ([@bib50]) by CD4, which has a higher affinity for LCK than CD8 ([@bib22]).

The stoichiometry between the coreceptors and LCK is a limiting factor for triggering the TCR signaling by suboptimal antigens ([@bib48]). Our mathematical model ([@bib48]) made two interesting predictions: (1) mature peripheral CD8^+^ T cells, but not CD4^+^ T cells, are more sensitive to suboptimal cognate antigens than DP thymocytes with the same specificity and (2) mature CD8^+^ T cells are more self-reactive than mature CD4^+^ T cells. Our experimental data using well-defined monoclonal MHCI- and MHCII-restricted T cells as well as polyclonal murine T cells supported the predictions of the model. The experiments using T cells expressing the chimeric CD8.4 coreceptor showed that the higher self-reactivity of CD8^+^ T cells compared to CD4^+^ T cells is at least partially caused by the differential developmental kinetics of the CD8-LCK versus CD4-LCK stoichiometries.

One of the key mechanisms of self-tolerance is the removal of overtly self-reactive T cell clones during negative selection in the thymus. However, the self-reactivity of positively selected mature T cells is beneficial for their survival and immune responses ([@bib31], [@bib13], [@bib49], [@bib46]). These two counteracting mechanisms generate a pressure for an optimal level of self-reactivity of mature T cells. Because the effector roles of CD4^+^ and CD8^+^ T cells in the immune responses are very different, it is very likely that the optimal level of self-reactivity differs between these two populations. However, the proximal TCR signaling pathway is identical in CD8^+^ and CD4^+^ T cells, which limits the possibilities of tuning the optimal level of self-reactivity for CD4^+^ and CD8^+^ T cells individually by evolutionary processes. The coreceptors represent the exceptional part of the TCR signaling machinery that differs between CD4^+^ and CD8^+^ T cells, and thus, it represents the ideal target for the evolutionary tuning of optimal self-reactivity of CD4^+^ and CD8^+^ T cells separately. The increase in CD8-LCK, but not CD4-LCK, stoichiometry during the maturation contributes to setting the higher level of self-reactivity of mature CD8^+^ T cells than of mature CD4^+^ T cells. Because CD4^+^ helper T cells modulate immune responses by acting on many other leukocytes, an autoimmune response of a CD4^+^ T cell might be more harmful than an autoimmune response of a CD8^+^ T cell. This might explain why we observed a buffering gap between the self-antigen affinity required for negative selection and affinity required for inducing an immune response in CD4^+^ T cells. In contrast, CD8^+^ T cells are able to induce a robust response to partial negative selectors and even to positive selectors. In the case of CD8^+^ T cells, the benefit from having a higher level of self-reactivity might overcome the risk of inducing autoimmunity.

Our findings were surprising because previous studies often suggested the opposite, i.e., that mature peripheral T cells are less sensitive to antigens than DP thymocytes ([@bib8], [@bib26], [@bib30]) and that peripheral CD4^+^ T cells are more self-reactive than CD8^+^ T cells ([@bib36]).

Our data highlight the role of CD8-LCK stoichiometry as the main cause of the increase in the responsiveness to suboptimal antigens, including self-antigens, upon maturation of CD8^+^ T cells. Moreover, pre-selection DP thymocytes exhibit substantially lower levels of surface TCR than mature T cells, which might also contribute to their lower sensitivity. In contrast, multiple mechanisms selectively enhancing the responses of thymocytes or suppressing the signaling in mature T cells were proposed (reviewed in [@bib14]). These mechanisms include sialyation of CD8 in peripheral T cells ([@bib45]) and higher expression of positive regulators of TCR signaling, a voltage-gated sodium channel ([@bib29]), Themis ([@bib3], [@bib12], [@bib19]), TESPA1 ([@bib53], [@bib27]), and miRNA-181a ([@bib26], [@bib8]) in thymocytes than in mature T cells.

Because our data concerning MHCII-restricted T cells do not show substantial differences between the immature and mature T cells, they are not in dramatic contrast to previous studies ([@bib8], [@bib26], [@bib30]). However, our data showing that CD8^+^ T cells increase their sensitivity to suboptimal antigens upon maturation are contradictory to some previous reports ([@bib6], [@bib45]). Most likely, differences in the experimental *ex vivo* protocols caused the discrepancy. For instance, the expression of costimulatory and inhibitory ligands on the APCs might selectively regulate responses of thymocytes and/or mature T cells. Thus, the usage of different cells as APCs could be the source of the inconsistencies among different studies. For this and other reasons, we believe that the *in vivo* data are more relevant than the *ex vivo* experiments. We showed that partial-negative-selecting and positive-selecting antigens are able to trigger a significant activation of CD8^+^, but not CD4^+^ T cells, *in vivo*. These experiments are in a very good agreement with previously published *in vivo* studies ([@bib21], [@bib24], [@bib25], [@bib59], [@bib9]), although a side-by-side comparison of CD8^+^ and CD4^+^ T cells has not been carried out previously.

The higher self-reactivity of CD4^+^ T cells than CD8^+^ T cells has been suggested based on the higher expression of *Nur77*-GFP and CD5 in CD4^+^ T cells than in CD8^+^ T cells ([@bib36], [@bib15]). However, it is possible that the transcription of these reporter genes is regulated in a cell-type-specific manner ([@bib36]). In such scenario, the markers are not reliable for a comparison between different T cell subsets. To avoid comparing apples and oranges, we examined CD8^+^ T cells and CD8.4^+^ T cells expressing a chimeric coreceptor, recapitulating the dynamics of CD4-LCK, but selecting MHCI-restricted T cells. CD8.4^+^ T cells showed lower basal expression of *Nur77*-GFP than CD8^+^ T cells. These results indicate that the changes in the coreceptor-LCK stoichiometry during maturation determine the self-reactivity of T cells. Moreover, the data suggest that the *Nur77*-GFP reporter is most likely differentially regulated in CD8^+^ and CD4^+^ T cells. To avoid artifacts caused by unique gene expression programs in CD4^+^ and CD8^+^ T cells, we focused on the basal TCR-dependent phosphorylation of TCRζ and ZAP70. We believe that this analysis of the proximal TCR signaling is the most reliable approach for the comparison of basal TCR signaling among different T cell subsets. It should be noted here that we cannot formally exclude that, besides LCK, other potential interacting partners of CD4 and/or CD8 might contribute to the differences between the CD8WT^+^ and CD8.4^+^ T cells.

Data about the coreceptor-LCK coupling in human immature and mature T cells are not available. Moreover, the level of self-reactivity of human CD4^+^ and CD8^+^ T cells has not been addressed. These parameters can be very different from mice. However, the principle of tuning the self-reactivity by the regulation of coreceptor-LCK stoichiometry could be very general because it represents an ideal target to set up the optimal self-reactivity of CD4^+^ and CD8^+^ T cells separately. Subsequent work should focus on the link between self-reactivity and coreceptor-LCK stoichiometry in human T cells.

Mice with point mutations disabling the CD8-LCK and/or CD4-LCK interactions would be required for a thorough understanding of the role of the coreceptor-LCK interaction in the T cell biology. However, our data suggest that targeting the CD4- and CD8-LCK interactions might reduce T cell self-reactivity. Thus, these interactions represent a potential target for the therapy of autoimmune diseases.

STAR★Methods {#sec5}
============

Key Resources Table {#sec5.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Armenian Hamster monoclonal anti-CD3ε (clone 145-2C11) APC conjugatedBD BiosciencesCat\# 553066, RRID:[AB_398529](nif-antibody:AB_398529){#intref0010}Armenian Hamster monoclonal anti-CD3ε (clone 145-2C11) PE conjugatedBD BiosciencesCat\# 553063, RRID:[AB_394596](nif-antibody:AB_394596){#intref0015}Goat polyclonal anti-CD3εSanta Cruz BiotechnologyCat\# sc-1127, RRID:[AB_631128](nif-antibody:AB_631128){#intref0020}Rat monoclonal anti-CD4 (clone RM4-4)BD Biosciences BioLegendCat\#: 553053, RRID: [AB_394588](nif-antibody:AB_394588){#intref0025}Cat\#: 116018, RRID: [AB_2650936](nif-antibody:AB_2650936){#intref0030}Rat monoclonal anti-CD4 (clone RM4-4) FITC conjugatedBioLegendCat\#: 116003, RRID: [AB_313688](nif-antibody:AB_313688){#intref0035}Rat monoclonal anti-CD4 (clone RM4-4) PE conjugatedBioLegendCat\# 116006, RRID: [AB_313691](nif-antibody:AB_313691){#intref0040}Rat monoclonal anti-CD4 (clone RM4-5) biotin conjugatedBD BiosciencesCat\# 553649, RRID:[AB_394969](nif-antibody:AB_394969){#intref0045}Rat monoclonal anti-CD4 (clone RM4-5) PE conjugatedBD BiosciencesCat\# 553049, RRID:[AB_394585](nif-antibody:AB_394585){#intref0050}Rat monoclonal anti-CD4 (clone RM4-5) BV650 conjugatedBioLegendCat\# 100545, RRID:[AB_11126142](nif-antibody:AB_11126142){#intref0055}Rat monoclonal anti-CD4 (clone RM4-5) APC conjugatedBD BiosciencesCat\# 553051, RRID:[AB_398528](nif-antibody:AB_398528){#intref0060}Rat monoclonal anti-CD4 (clone RM4-5) AF700 conjugatedBD BiosciencesCat\# 557956, RRID:[AB_396956](nif-antibody:AB_396956){#intref0065}Rat monoclonal anti-CD4 (clone H129.19) PE conjugatedBD BiosciencesCat\# 553652, RRID:[AB_394972](nif-antibody:AB_394972){#intref0070}Rat monoclonal anti-CD4 (clone H129.19) FITC conjugatedBD BiosciencesCat\# 553651, RRID:[AB_394971](nif-antibody:AB_394971){#intref0075}Rat monoclonal anti-CD4 (clone GK1.5) Alexa Fluor 488 cojungatedBiolegendCat\# 100423, RRID:[AB_389302](nif-antibody:AB_389302){#intref0080}Rabbit monoclonal anti-CD4 (clone D7D2Z)Cell Signaling TechnologyCat\# 25229, RRID:[AB_2798898](nif-antibody:AB_2798898){#intref0085}Rat monoclonal anti-CD4 (clone YTS 177.9) biotin conjugatedTomas Brdicka's labN/ARat monoclonal anti-CD8a (clone 53-5.7) FITC conjugatedBD Biosciences BioLegendCat\# 553032, RRID:[AB_394570](nif-antibody:AB_394570){#intref0090}Cat\# 100706, RRID:[AB_312745](nif-antibody:AB_312745){#intref0095}Rat monoclonal anti-CD8a (clone 53-5.7) BV421 conjugatedBioLegendCat\# 100737, RRID:[AB_10897101](nif-antibody:AB_10897101){#intref0100}Rat monoclonal anti-CD8a (clone 53-5.7) PE conjugatedBD BiosciencesCat\# 553033, RRID:[AB_394571](nif-antibody:AB_394571){#intref0105}Rabbit monoclonal anti-CD8a (clone D4W2Z)Cell Signaling TechnologyCat\# 98941, RRID:[AB_2756376](nif-antibody:AB_2756376){#intref0110}Rat monoclonal anti-CD8b.2 (clone 53-5.8)BD BiosciencesCat\# 553038, RRID:[AB_394574](nif-antibody:AB_394574){#intref0115}Rat monoclonal anti-CD8b.2 (clone 53-5.8) Biotin cojugatedBD BiosciencesCat\# 553039, RRID:[AB_394575](nif-antibody:AB_394575){#intref0120}Rat monoclonal anti-CD8b.2 (clone 53-5.8) FITC conjugatedBD BiosciencesCat\# 553040, RRID:[AB_394576](nif-antibody:AB_394576){#intref0125}Rat monoclonal anti-CD8b.2 (clone 53-5.8) PerCP-Cy5.5 conjugatedBioLegendCat\# 140417, RRID:[AB_2800650](nif-antibody:AB_2800650){#intref0130}Rat monoclonal anti-CD8b (clone eBioH35-17.2) PE-Cy7 conjugatedThermo Fisher ScientificCat\# 25-0083-82, RRID:[AB_11218494](nif-antibody:AB_11218494){#intref0135}Rat monoclonal anti-CD11b (clone YBM 15.1.6) biotin conjugatedTomas Brdicka's labN/ARat monoclonal anti-CD25 (clone PC61) PE-Cy7 conjugatedBioLegendCat\# 102016, RRID:[AB_312865](nif-antibody:AB_312865){#intref0140}Rat monoclonal anti-CD44 (clone IM7) PerCP-Cy5.5 conjugatedBioLegendCat\# 103032, RRID:[AB_2076204](nif-antibody:AB_2076204){#intref0145}Rat monoclonal anti-CD44 (clone IM7) BV650 conjugatedBioLegendCat\# 103049, RRID:[AB_2562600](nif-antibody:AB_2562600){#intref0150}Rat monoclonal anti-CD44 (clone IM7) biotin conjugatedBioLegendCat\# 103003, RRID:[AB_312954](nif-antibody:AB_312954){#intref0155}Mouse monoclonal anti-CD45.2 (clone 104) APC-Cy7 conjugatedBD BiosciencesCat\# 560694, RRID:[AB_1727492](nif-antibody:AB_1727492){#intref0160}Mouse monoclonal anti-CD45.2 (clone 104) Alexa Fluor 700 conjugatedBiolegendCat\# 109822, RRID:[AB_493731](nif-antibody:AB_493731){#intref0165}Rat monoclonal anti-CD45R/B220 (clone RA3-6B2) biotin conjugatedBD BiosciencesCat\# 553085, RRID:[AB_394615](nif-antibody:AB_394615){#intref0170}Rat monoclonal anti-CD62L (clone MEL-14) PE-Cy7 conjugatedBioLegendCat\# 104418, RRID:[AB_313103](nif-antibody:AB_313103){#intref0175}Armenian Hamster monoclonal anti-CD69 FITC conjugatedBD BiosciencesCat\# 553236, RRID:[AB_394725](nif-antibody:AB_394725){#intref0180}Mouse monoclonal anti-Lck (clone 3a5)Santa Cruz BiotechnologyCat\# sc-433, RRID:[AB_627880](nif-antibody:AB_627880){#intref0185}Mouse monoclonal anti-Lck (clone 3a5) PE conjugatedSanta Cruz BiotechnologyCat\# sc-433 PE, RRID: N/AMouse monoclonal anti-MHCI (H2Kb; clone Y3.8)Ed Palmer's lab, University of BaselN/AArmenian Hamster monoclonal anti-TCRβ (clone H57-597) APC conjugatedBD Biosciences BiolegendCat\# 553174, RRID:[AB_398534](nif-antibody:AB_398534){#intref0190}Cat\# 109212, RRID:[AB_313435](nif-antibody:AB_313435){#intref0195}Rabbit monoclonal anti-Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (clone D13.14.4E)Cell Signaling TechnologyCat\# 4370, RRID:[AB_2315112](nif-antibody:AB_2315112){#intref0200}Mouse monoclonal anti-Src, non-phospho (Tyr416) (clone 7G9)Cell Signaling TechnologyCat\# 2102, RRID:[AB_331358](nif-antibody:AB_331358){#intref0205}Rabbit polyclonal anti-Phospho-Src Family (Tyr416)Cell Signaling TechnologyCat\# [2101](mi:2101){#intref0210}, RRID:[AB_331697](nif-antibody:AB_331697){#intref0215}Mouse monoclonal anti-Phosphotyrosine (clone 4G10) PE conjugatedMilliporeCat\# FCMAB323PE, RRID:[AB_10805942](nif-antibody:AB_10805942){#intref0220}Mouse monoclonal anti-CD247 phospho (Tyr142) (clone K25-407.69) PE conjugatedBD BiosciencesCat\# 558448, RRID:[AB_647237](nif-antibody:AB_647237){#intref0225}Rabbit monoclonal anti-Phospho-Zap-70 (Tyr319)/Syk (Tyr352) (clone 65E4)Cell Signaling TechnologyCat\# 2717, RRID:[AB_2218658](nif-antibody:AB_2218658){#intref0230}Mouse monoclonal anti-Lamin B1 (clone 119D5-F1)Santa Cruz BiotechnologyCat\# sc-56143, RRID:[AB_2136302](nif-antibody:AB_2136302){#intref0235}Mouse monoclonal anti-Zap70 (clone 1E7.2) Alexa Fluor 488 conjugatedThermo Fisher ScientificCat\# MHZAP7020, RRID:[AB_10375316](nif-antibody:AB_10375316){#intref0240}Rabbit polyclonal anti-GAPDHSigma-AldrichCat\# G9545, RRID:[AB_796208](nif-antibody:AB_796208){#intref0245}Donkey polyclonal anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 555 conjugatedThermo Fisher ScientificCat\# A-31572, RRID:[AB_162543](nif-antibody:AB_162543){#intref0250}Goat polyclonal anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 555 conjugatedThermo Fisher ScientificCat\# A-21429, RRID:[AB_2535850](nif-antibody:AB_2535850){#intref0255}Goat polyclonal anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 conjugatedThermo Fisher ScientificCat\# A-11034, RRID:[AB_2576217](nif-antibody:AB_2576217){#intref0260}Goat polyclonal anti-mouse IgG (H+L) Secondary Antibody, HRP conjugatedJackson ImmunoResearch LabsCat\# 115-035-003, RRID:[AB_10015289](nif-antibody:AB_10015289){#intref0265}Donkey polyclonal anti-Goat IgG (H+L) antibody, HRP conjugatedJackson ImmunoResearch LabsCat\# 705-035-003, RRID:[AB_2340390](nif-antibody:AB_2340390){#intref0270}Goat polyclonal anti-rabbit IgG (H+L) Secondary Antibody, HRP conjugatedJackson ImmunoResearch LabsCat\# 111-035-003, RRID:[AB_2313567](nif-antibody:AB_2313567){#intref0275}**Bacterial and Virus Strains***Listeria monocytogenes* (transfected with empty pPL1,pPL2)([@bib59])N/A*Listeria monocytogenes* expressing SIINFEKL (OVA) peptide (transfected with pPL1,pPL2 carrying OVA peptide coding sequence)([@bib59])N/A*Listeria monocytogenes* expressing SIITFEKL (T4) peptide (transfected with pPL1,pPL2 carrying T4 peptide coding sequence)([@bib59])N/A*Listeria monocytogenes* expressing SIIQFEHL (Q4H7) peptide (transfected with pPL1,pPL2 carrying Q4H7 peptide coding sequence)([@bib24])N/A*Listeria monocytogenes* expressing FEAQKAKANKAVD (3K) peptide (transfected with pPL1,pPL2 carrying 3K peptide coding sequence)This paperN/A*Listeria monocytogenes* expressing FEAAKAKANKAVD (P2A) peptide (transfected with pPL1,pPL2 carrying P2A peptide coding sequence)This paperN/AListeria monocytogenes expressing FAAQKAKANKAVD (P-1A) peptide (transfected with pPL1,pPL2 carrying P-1A peptide coding sequence)This paperN/A**Chemicals, Peptides, and Recombinant Proteins**AccuCheck Counting BeadsThermo Fisher ScientificCat\# PCB100Qdot 605 Streptavidin ConjugateInvitrogenCat\# Q10103MPCML Latex Beads, 4% w/v, 5 μmThermo Fisher ScientificCat\# C37255Nonidet P 40 SubstituteSigma AldrichCat\# 74385n-Dodecyl-beta-Maltoside DetergentThermo Fisher ScientificCat\# 89903cOmplete, EDTA-free Protease Inhibitor Cocktail TabletsRocheCat\# 050564890014-(2-Aminoethyl)benzenesulfonyl fluoride hydrochlorideSigma AldrichCat\# A8456PhosSTOPRoche Molecular Systems, IncCat\# 04906837001Amersham Protran 0.45 NC nitrocellulose western blotting membranesGE HealthcareCat\# 10600002Streptavidin Mag SepharoseGE HealthcareCat\# 28985738LPS *E.Coli* O111:B4Sigma AldrichCat\# LPS25OVA peptide (SIINFEKL)EurogentecRef\# AS-60193-1T4 peptide (SIITFEKL)EurogentecRef\# AS-64403Q4H7 peptide (SIIQFEHL)EurogentecRef\# AS-644053K peptide (FEAQKAKANKAVD)Peptides and ElephantsN/AP2A peptide (FEAAKAKANKAVD)Peptides and ElephantsN/AP-1A peptide (FAAQKAKANKAVD)Peptides and ElephantsN/A(+)-Biotin N-hydroxysuccinimide esterSigma AldrichCat\# H1759Sephadex® G-25Sigma AldrichCat\# S5772**Critical Commercial Assays**LIVE/DEAD Fixable Near-IR Dead Cell Stain KitThermo Fisher ScientificL34976CellTrace CFSE Cell Proliferation KitThermo Fisher ScientificC34554Untouched Mouse CD8 Cells KitDynabeadsCat\# 11417DUntouched Mouse CD4 Cells KitDynabeadsCat\# 11415DBiotin BinderDynabeadsCat\# 11047EasySep Mouse CD8 T Cell Enrichment KitStem CellCat\# 19753ARNA Clean and Concentrator^-5^Zymo ResearchCat\# R1013Neuraminidase from Vibrio cholera, type IISigma AldrichCat\# N6514**Experimental Models: Cell Lines**LutzN/AN/A**Experimental Models: Organisms/Strains**Mouse: C57BL/6JAnimal Facility of Institute of Molecular GeneticsJAX 000664Mouse: C57BL/6J CD45.1([@bib42])JAX 002014Mouse: CD3ε^−/−^([@bib44])JAX 004177Mouse: CD8.4([@bib10])N/AMouse: OT-I Rag2^−/−^([@bib16], [@bib43])N/AMouse: B3K508 Rag2^−/−^([@bib17], [@bib43])N/AMouse: FoxP3^−/−^([@bib28])JAX 019933Mouse: Nur77-GFP([@bib36])JAX 016617Mouse: FoxP3-GFP([@bib11])N/AMouse: FoxP3-DTR([@bib23])JAX 016958Mouse: Lck^−/−^This paperN/A**Oligonucleotides**CD8 Forward -- CCGTGGCTCAGTGAAGGGGSigma AldrichN/ACD8' Reverse -- CTGACTAGCGGCTGTGGTAGCSigma AldrichN/ACD8 Full length Reverse -- CATTTGCAAACACGCTTTCGGCTCSigma AldrichN/ACD8 Total Reverse - CTTGCCTTCCTGTCTGACTAGCSigma AldrichN/AgRNA for Lck^−/−^ generation: TTGCTGTCCAGTGGGACTAT **GGG**N/AN/A**Software and Algorithms**Source code for 'Lck come&stay/signal duration' model (MATLAB)This paper ([Data S1](#mmc1){ref-type="supplementary-material"})N/AGraphPad Prism 5.04GraphPad SoftwareN/AFlowJo V9 and V10FlowJo, LCCN/AR Studio V1.2.1335RStudio, Inc.N/ATescan Q-Phase software V7.727Tescan Orsay Holding, a.sN/AFiji (ImageJ version 1.52i)Open SourceN/AMATLABMathWorksN/A**Other**LSRIIBD BiosciencesN/ACantoIIBD BiosciencesN/AFACSymphonyBD BiosciencesN/ALSRFortessaBD BiosciencesN/AInflux SorterBD BiosciencesN/ACytek™ AuroraCytekN/ALI-COR Odyssey infrared imaging systemLI-COR BiosciencesN/AAzure c200 imaging systemAzure BiosystemsN/AZ2 Coulter Counter AnalyzerBeckman CoulterN/ALightCycler® 480 Instrument IIRoche Molecular Systems, IncN/A

Lead Contact and Materials Availability {#sec5.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ondrej Stepanek (<ondrej.stepanek@img.cas.cz>). All unique/stable reagents (i.e., *Listeria monocytogenes* strains and *Lck*^−/−^ mouse strain) generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

Experimental Model and Subject Details {#sec5.3}
--------------------------------------

### Mice {#sec5.3.1}

All mice had C57BL/6J background and were 6-20 weeks old. Both males and females were used for experiments. For adoptive T cell transfers, only females were used as donors. *Foxp3*-deficient mice and littermate controls were analyzed at the age of 2-3 weeks old. Mice were bred in our SPF facilities (University Hospital Basel and Institute of Molecular Genetics) in accordance with Cantonal and Federal laws of Switzerland and the laws of the Czech Republic. Animal protocols were approved by the Cantonal Veterinary Office of Basel‐Stadt, Switzerland, and the Czech Academy of Sciences, Czech Republic. The used strains were: Ly5.2, Ly5.1 ([@bib42]), *Cd3ε*^−/−^ ([@bib44]), CD8.4 ([@bib10]), OT-I *Rag2*^−/−^ ([@bib16], [@bib43]), B3K508 *Rag2*^−/−^ ([@bib17], [@bib43]), *Foxp3*-deficient ([@bib28]), *Nur77*-GFP ([@bib36]), *Foxp3*-GFP ([@bib11]), *Foxp3*-DTR ([@bib23]). Strains CD8.4 and *Nur77*-GFP were bred to obtain strain CD8.4 *Nur77*-GFP. Mice were kept in the animal facility with 12 hours of light and dark cycle with food and water *ad libitum*.

*Lck*^*−/−*^ mice were generated on C57BL/6J background in the Czech Centre for Phenogenomics, Institute of Molecular Genetics, ASCR. The mice were generated by pronuclear microinjection of Cas9 mRNA and gRNA (TTGCTGTCCAGTGGGACTAT GGG) at concentration 100 ng/μl, into one-cell-stage murine embryos as described previously ([@bib20]). The *Lck*^*+/−*^ mice were backcrossed on C57BL/6J background at least 5 generations. The mice bear a deletion of 75-82 nt in the exon 2 (transcript ID: ENSMUST00000067240.10) of *Lck* gene, resulting in a frameshift and early termination of translation.

### Bone marrow-derived dendritic cells (BMDC) {#sec5.3.2}

Dendritic cells were derived from fresh or immortalized ([@bib7], [@bib40]) hematopoietic stem cells. The cells were seeded on 100 mm non-treated plates and maintained in D-MEM (Sigma Aldrich) containing 10% FBS (GIBCO), 100 U/ml penicillin (BB Pharma), 100 μg/ml streptomycin (Sigma Aldrich), 40 μg/ml gentamicin (Sandoz) and 2% of supernatant from Lutz cells for 7 days at 5% CO~2~, 37°C. The cells were split and media was refreshed every 2-3 days. On day 7, 100 ng/ml LPS (Sigma Aldrich) was added and the cells were seeded on 96-well plate at frequency 0.5 × 10^6^ cells/ml.

Method Details {#sec5.4}
--------------

### Flow cytometric immunoprecipitation assay {#sec5.4.1}

Peripheral CD8^+^ and CD4^+^ T cells were enriched by magnetic beads (Dynabeads) and FACS-sorted CD4^+^CD8^+^ CD3^LOW^ preselection thymocytes were used for the flow cytometric immunoprecipitation assay. 10^7^ cells were lysed in 50 μl lysis buffer (1% NP-40S, 50 mM Tris pH 7.4, 150 mM NaCl, AEBSF protease inhibitor (Sigma Aldrich)) for 30 min on ice. 75,000 CML beads (Invitrogen) coupled to anti-CD4 (RM4.4), anti-CD8β (53-5.8), or anti-MHCI (Y3.8) antibodies, as described previously ([@bib41]), were added to the lysate and incubated for 1 hr at 4°C. Beads were washed 3x in the lysis buffer and stained with different PE-conjugated antibodies specific to CD4 (H129.19, 8 μg/mL), CD8α (53-6.7, 20 μg/mL), or LCK (3A5, 67 μg/mL) at saturating concentrations (30 min, on ice) and analyzed by flow cytometry. The geometric mean fluorescence intensities (gMFI) were taken as the measure of the antibody binding. The CD8, CD8.4 or CD4-LCK coupling ratio was calculated as LCK signal to CD8 or CD4 signal (after subtracting respective background signal measured from control anti-MHCI beads) and adjusted for the PE/antibody ratio.

### Analysis of soluble and insoluble fractions {#sec5.4.2}

10^7^ thymocytes or peripheral LN cells were lysed in 50 μl lysis buffer (1% NP-40S, 50 mM Tris pH 7.4, 150 mM NaCl, complete protease inhibitor cocktail (Roche)) for 30 min on ice. The samples were centrifuged and the soluble fraction was separated from the insoluble fraction. The insoluble fraction was washed in the lysis buffer and then resuspended in the same volume of the lysis buffer as the separated supernatant. Concentrated Laemmli sample buffer was added to the final concentration: 62.5 mM Tris, 10% glycerol, 1% SDS, 0.005% Bromphenol Blue, 50 mM DTT. The samples were incubated at 94°C (3 min). The NP-40S-insoluble fraction was dissolved by sonication. The samples were immunoblotted using antibodies to CD4 (D7D2Z), CD8α (D4W2Z), LCK (3a5), CD3ε (goat polyclonal), GAPDH (rabbit polyclonal), lamin B1 (119D5-F1) and visualized with HRP conjugated goat anti-mouse, goat anti-rabbit or donkey anti-goat antibodies using an Azure c200 imaging system.

### Immunoprecipitation of surface coreceptors {#sec5.4.3}

Total thymocytes or peripheral CD8^+^ and CD4^+^ T cells enriched by negative magnetic beads separation (Dynabeads, StemCell) were used for immunoprecipitation. 2-3 × 10^7^ of live cells were stained with biotinylated anti-CD8β (53-5.8) or anti-CD4 (H129.19) antibodies. Cells were lysed in 1 mL lysis buffer (1% Lauryl-β-D-maltoside (Thermo Fisher Scientific), 30 mM Tris, 120 mM NaCl, 2 mM KCl, 10% glycerol, 50x complete protease inhibitors (Roche)), lysate was cleared by centrifugation and supernatant was incubated with Streptavidin Mag Sepharose (GE Healthcare) for 2 hr at 4°C. Washed beads were lysed in Laemmli sample buffer. Samples were subjected to immunoblotting with rabbit mAb CD8α (D4W2Z) or CD4 (D7D2Z) and LCK (3A5) and visualized with goat anti-rabbit or goat anti-mouse antibodies conjugated with AF680 on LI-COR Odyssey infrared imaging system. Quantification analysis was done using FIJI software.

### Neuraminidase treatment {#sec5.4.4}

Total 10^7^ thymocytes or peripheral T cells were treated by 0.08 U of type II neuraminidase from *Vibrio cholerae* (Sigma) for 1 hour at 37°C in RPMI (Sigma). The cells were then either stained for flow cytometry analysis: using saturating concentration of anti-CD8β-APC (4 μg/ml, clone 53-5.8), together with anti-CD8α-AlexaFluor488 (clone 53-6.7) at a saturating concentration of 20 μg/ml or a non-saturating concentration of 32 ng/ml; or lysed in 300 μL lysis buffer (see immunoprecipitation of cell surface coreceptors for details) for 30 minutes on ice and centrifuged (20,000 g, 5 min). The supernatant was diluted in 4x concentrated Laemmli sample buffer. Samples were subjected to immunoblotting with rabbit mAb CD8α (D4W2Z) and visualized with goat anti-rabbit antibody conjugated with AF680 on LI-COR Odyssey infrared imaging system. Quantification analysis was done using FIJI software.

### Quatitative PCR {#sec5.4.5}

RNA was isolated from total thymocytes or sorted CD4^+^ or CD8^+^ peripheral T cells using TRIzol™ LS (Ambien) and RNA Clean & Concentrator^-5^ (Zymo Research). The RNA was converted to cDNA using RevertAid Reverse Transcriptase (Thermo Fisher Scientific). Quantitative PCR analysis was performed using LightCycler® 480 SYBR Green I Master (Roche) in LightCycler® 480 Instrument II (Roche).

### Mathematical model {#sec5.4.6}

The analytical solution of the 'LCK come&stay/signal duration' mathematical model was described previously ([@bib48]). The model predicts number of occupied and triggered TCRs at any time as described previously. The parameters for the model were used as described previously for thymocytes ([@bib48]) or obtained experimentally for LN T cells ([Figures S1](#mmc1){ref-type="supplementary-material"}J--S1M; [Table S1](#mmc1){ref-type="supplementary-material"}). The calculations were performed in MATLAB (MathWorks). The script is included as [Data S1](#mmc1){ref-type="supplementary-material"}.

### T cell enrichment {#sec5.4.7}

CD8, CD8.4, or CD4 T cells were enriched by negative selection using kits from Dynabeads or StemCell or Dynabeads Biotin Binder kit using biotinylated anti-CD4 (YTS 177.9), anti-CD11b (YBM 15.1.6), anti-CD45R/B220 (RA3-6B2), and eventually anti-CD44 (IM7) antibodies. The anti-CD4 and anti-CD11b antibodies were produced and biotinylated in house using (+)-Biotin *N*-hydroxysuccinimide ester (Sigma Aldrich) in bicarbonate buffer. The excess biotin was separated from the antibody using Sephadex G-25 (Sigma Aldrich).

### Flow cytometry analysis and sorting {#sec5.4.8}

Live cells were stained with relevant antibodies and LIVE/DEAD Near-IR viability dye on ice. For intracellular staining, cells were fixed in 4% formaldehyde (15 min, RT) immediately after isolation, permeabilized by 90% methanol (30 min, on ice) and stained with indicated antibodies at RT. The cells were analyzed on LSRII, FACSCantoII, LSRFortessa, FACSymphony (BD Bioscience) or on Aurora (Cytek). The cells were sorted on Influx sorter (BD Bioscience). For the analysis of pTCRζ and pZAP70 and overall tyrosine phosphorylation in *Lck*+/+, *Lck*^+/−^ and *Lck*^−/−^ mice, the LN cells from these three mice were fixed and permeabilized and multiplexed by separate staining of CD45.2 (antibody clone 104) conjugated with two different fluorophores (AF700, APC-Cy7) or their combination and mixed prior to the staining with phospho-specific antibodies. The usage of particular fluorophores for particular mouse stain was different for each experiment to avoid any possible effects of the fluorophores on the results.

### Determination of LCK phosphorylation status {#sec5.4.9}

LCK was immunoprecipitated from untreated or PP2-treated B3K508 and OT-I T cells and analyzed by immunoblotting. Signals from antibodies recognizing phosphorylated and non-phosphorylated LCK (Y394) were normalized to total LCK and the percentage of phosphorylated molecules was calculated as previously described ([@bib47], [@bib48]). Because we did not observe a difference in the pLCK/total LCK ratios between B3K508 and OT-I T cells, we pooled the data from B3K508 and OT-I T cells to estimate the percentage of phosphorylated LCK molecules in peripheral T cells.

### Determination of TCR and coreceptor levels {#sec5.4.10}

The number of the TCR molecules and CD4 and CD8 coreceptors on the peripheral T cells was determined by flow cytometry as previously described ([@bib48]).

### Antigen presentation assay {#sec5.4.11}

BMDCs were cultivated from fresh or immortalized ([@bib7], [@bib40]) hematopoietic stem cells. The dendritic cells were pulsed with indicated concentration of indicated peptides and mixed with isolated T cells or thymocytes in ratio 1:1 or 1:2 and co-cultured in RPMI (Sigma Aldrich) containing 10% FBS (GIBCO), 100 U/ml penicillin (BB Pharma), 100 μg/ml streptomycin (Sigma Aldrich), 40 μg/ml gentamicin (Sandoz) for indicated period of time (pERK1/2 analysis) or over-night (CD25 and CD69 analysis). The EC~50~ values for the CD69 upregulation assay were calculated using non-liner fit (log(agonist) versus response--Variable slope (four parameters)) in GraphPad Prism 5. The cell numbers were counted using Z2 Coulter Counter Analyzer (Beckman Coulter).

### Listeria infection {#sec5.4.12}

The LN T cells were isolated from B3K508 and OT-I mice and loaded with CFSE. The CFSE labeling of the cells was verified by flow cytometry and the cells were simultaneously counted using AccuCheck Counting beads (Thermo Fisher Scientific). The cells were adoptively transferred to Ly5.1 congenic host mice. The mice were injected with 5000 CFU of transgenic *Listeria monocytogenes* (Lm) expressing peptides OVA, T4, 3K and P-1A as described previously ([@bib21], [@bib59]). The expression of CD25, CFSE dilution, and cell expansion were analyzed 4 days after infection. Preceding flow cytometry analysis, the cells were enriched using negative magnetic bead separation kit for CD4^+^ or CD8^+^ cells (for samples with adoptively transferred B3K508 and OT-I cells respectively; Dynabeads).

### Quantitative phase imaging {#sec5.4.13}

Cells isolated from WT and CD8.4 mice were stained with anti-CD4-Alexa Fluor 488 (RM4-5), anti-CD8α-Brilliant Violet 421 (53-5.7) and anti-CD44 (IM7, biotin conjugate) antibodies, further stained with Qdot 605 Streptavidin Conjugate and observed under Tescan Q-Phase microscope (Tescan Orsay Holding) equipped with Nikon DS-Qi1Mc camera. Samples were kept in a climatic box with stable 37°C and 5% CO2 and imaged using 20x/0.5 dry objective. Data were analyzed using Tescan Q-Phase software and RStudio.

### Antibody competition binding assay {#sec5.4.14}

0.5 × 10^6^ cells isolated from LN of C57BL/6J mice were stained first with saturating concentration of anti-CD4 antibody conjugated with FITC (RM4-4 or H129.19), then washed three times and stained with saturating concentrations of anti-CD4 antibody conjugated with PE (RM4-4 or H129.19). Single stained cells served as controls. The fluorescence was analyzed using a FACSymphony (BD Biosciences).

Quantification and Statistical Analysis {#sec5.5}
---------------------------------------

Data were displayed as Mean or Mean + SEM. Statistical analysis was performed with the two-tailed Mann-Whitney test, the one-value t test (after the data passed the Kolmogorov--Smirnov normality test), paired t test, or Kruskall-Wallis test whenever appropriate as indicated. Statistical analysis was performed in Graphpad Prism 5. The quantification of western blots was performed in FIJI. The dry mass analysis was performed in Tescan Q-Phase software and evaluated in RStudio. The area under curve was calculated in Excel.

Data and Code Availability {#sec5.6}
--------------------------

The 'LCK come&stay/signal duration' mathematical model script is included as [Data S1](#mmc1){ref-type="supplementary-material"}. Software used is described in [Key Resources Table](#sec5.1){ref-type="sec"}.
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